CD8A and neoplasm: Given the significantly increased number and activity of CD8+ T cells in the orthotopic KPC model of AB680‐treated mice, accompanied by a reduction in tumor burden, we further investigated whether the antitumor effect of AB680 could be impaired by the depletion of CD8+ T cells (Figure 4I).